Search filters

List of works by David G. Maloney

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials ⬇️

scientific article published on October 1, 2003

90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution

scientific article

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911 ⬇️

scientific article published on May 8, 2003

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

scientific article

Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products

scientific article published on 12 September 2017

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

scientific article

Acute renal failure after nonmyeloablative hematopoietic cell transplantation

scientific article

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

scientific article published on 2 October 2003

Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition

scientific article published on March 2014

Agranulocytosis unresponsive to growth factors following rituximab in vivo purging ⬇️

scientific article published on May 15, 2003

Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas

scientific article

Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience

scientific article published on 25 July 2016

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

scientific article

Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects

scientific article published on 14 February 2013

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

scientific article published on 04 June 2020

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant ⬇️

scientific article published on April 1, 2003

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

scientific article

Anti-CD20 Antibody Therapy for B-Cell Lymphomas ⬇️

scientific article published on May 24, 2012

Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy

scientific article published in 2023

Antibody-directed therapies for hematological malignancies

scientific article

Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation ⬇️

scientific article published on August 26, 2011

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research

scientific article published on 27 November 2012

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

scientific article published on 06 July 2013

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial ⬇️

scientific article published on September 29, 2011

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

scientific article published on 16 December 2013

Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity

scientific article

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research

scientific article

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

scientific article published on 25 April 2016

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results ⬇️

scientific article published on February 3, 2012

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

article by Michael M Boyiadzis et al published 4 December 2018 in Journal for Immunotherapy of Cancer

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

scientific article published on 18 December 2018

Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape

scientific article published on 20 June 2016

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma

scientific article published on 13 June 2016

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation

scientific article published on 27 August 2007

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

scientific article

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors

scientific article

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

scientific article published on 27 April 2004

Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation

scientific article

Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation

scientific article published in April 2005

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

scientific article

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

scientific article published on 22 January 2018

Cooperative epigenetic modulation by cancer amplicon genes

scientific article

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs ⬇️

scientific article published on August 31, 2011

Decreased Serum Albumin as a Biomarker for Severe Acute Graft-versus-Host Disease after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation ⬇️

scientific article published on July 30, 2011

Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia

scientific article published on 30 June 2009

Diversity in antibody-based approaches to non-Hodgkin lymphoma ⬇️

scientific article published on August 1, 2010

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose

scientific article

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation

scientific article

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib

scientific article published on 17 July 2017

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

scientific article

Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation

scientific article published on December 2008

Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation

scientific article published on 16 April 2009

Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma

scientific article published on June 2008

Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation

scientific article published in December 2002

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

scientific article

Factors affecting antibody levels after allogeneic hematopoietic cell transplantation

scientific article published on 27 December 2002

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

scientific article published on 06 February 2019

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

scientific article published on 08 August 2006

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone ⬇️

scientific article published on January 22, 2012

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

scientific article published on 15 September 2008

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial

scientific article

Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects

scientific article published on January 2007

Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.

scientific article published in September 2002

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

scientific article

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

scientific article published on 11 March 2013

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

scientific article

Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma

scientific article published on January 2003

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

scientific article published in April 2005

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

scientific article

Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study

scientific article published on 13 June 2016

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

scientific article

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

scientific article

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

scientific article

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

scientific article published in May 2008

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

scientific article published on 11 September 2003

High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma

scientific article

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma

scientific article published on 20 February 2007

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

scientific article published in May 2002

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

scientific article published on 15 May 2003

High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience

scientific article published on September 2008

High-throughput identification of promiscuous inhibitors from screening libraries with the use of a thiol-containing fluorescent probe

scientific article

Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation

scientific article

Hodgkin lymphoma

scientific article published on 01 September 2011

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines

scientific article published in May 2012

Hodgkin lymphoma, version 2.2015.

scientific article

Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma

scientific article published on 03 April 2011

Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation ⬇️

scientific article published on September 18, 2012

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning ⬇️

scientific article published on October 1, 2003

Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines

scientific article

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

scientific article published on September 2016

Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma

scientific article

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation

scientific article

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma

scientific article published on February 2013

Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation ⬇️

scientific article published on May 26, 2010

Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation

scientific article published in November 2003

Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy

scientific article published on July 2006

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

scientific article published on January 2002

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

scientific article published in March 2002

Indolent lymphomas: current and emerging treatment approaches

scientific article published on September 2006

Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy

scientific article published on 16 October 2017

Inhibition of DNA glycosylases via small molecule purine analogs

scientific article

Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys

scientific article

Interleukin-7 improves reconstitution of antiviral CD4 T cells

scientific article

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.

scientific article

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

scientific article

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

scholarly article by Enrico Maffini et al published February 2019 in Haematologica

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting

scientific article

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

scientific article published on November 2011

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation

scientific article

Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

scientific article

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

scientific article published on 3 October 2002

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

scientific article

Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy

scientific article published on 18 March 2019

Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation ⬇️

scientific article published on July 5, 2011

Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies

scientific article published on 19 September 2005

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

scientific article published on 18 May 2004

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

scientific article published on 5 May 2015

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma

scientific article

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

scientific article

New treatment options have changed the survival of patients with follicular lymphoma

scientific article

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

scientific article published on 28 August 2008

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

scientific article published in January 2003

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia ⬇️

scientific article published on April 20, 2011

Non-myeloablative transplantation.

scientific article

Nonmyeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenstrom macroglobulinemia: Evidence for a graft-versus-lymphoma effect.

scientific article

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia

scientific article

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

scientific article published on 3 December 2007

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

scientific article published on 08 December 2008

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

scientific article

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma

scientific article

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

scientific article

Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor

scientific article published on 10 June 2013

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

scientific article published on 8 August 2006

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia

scientific article published in January 2005

Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease

scientific article published on 20 July 2015

Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma

scientific article published in 2022

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

scientific article

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission

scientific article

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

scientific article

Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission

scientific article

Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome

scientific article

Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

scientific article

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

scientific article

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome ⬇️

scientific article published on October 1, 2003

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

scientific article

Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial

scientific article published on 12 October 2017

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

scientific article published on 10 July 2003

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning ⬇️

scientific article published on April 10, 2003

Rituximab for follicular lymphoma.

scientific article

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

scientific article published on 5 October 2017

Rituximab resistance ⬇️

scientific article published on April 13, 2011

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience

scientific article published on 03 September 2019

Rituximab: mechanism of action and resistance

scientific article

Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts

scientific article published on 03 August 2009

Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation

scientific article published on 17 July 2013

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia

scientific article published on January 2011

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

scientific article published on 09 November 2017

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

scientific article

The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation

scientific article published on 11 January 2010

The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation

scientific article published in October 2007

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

scientific article published on 19 February 2019

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.

scientific article published on 13 February 2018

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

scientific article

Treatment of follicular non-Hodgkin's lymphoma

scientific article

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

scientific article

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

scientific article

Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning

scientific article published in November 2006

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

scientific article

Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia

scientific article published on 12 January 2006

What is the role for donor natural killer cells after nonmyeloablative conditioning?

scientific article published on May 2009

What is the role of maintenance rituximab in follicular NHL?

scientific article published on January 2008

⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma

scientific article published on 20 April 2011

Paulina is supported by:

About Paulina

Help